4th Applied Biocatalysis and Enzyme Engineering Summit

Welcome to a pivotal moment in the Golden Age of Biocatalysis, where industry leaders like Eli Lilly and Pfizer are transforming small molecule operations and biopharma is pushing the boundaries of biologics development. This year, we're witnessing ground breaking advancements as biocatalysis becomes central to biologics and therapeutic innovation.

In collaboration with Merck, Novo Nordisk and Pfizer, we're excited to bring you the 4th Applied Biocatalysis and Enzyme Engineering Summit - now with a sharper focus on enzyme engineering and expanded coverage of biocatalysis-derived oligonucleotides, peptides and other large biologics. Plus, dive into brand-new biopharma case studies designed to boost enzyme efficiency and therapeutic yields.

Why Attend?

- Revolutionize Biologics Development: Discover cutting-edge oligonucleotide production case studies that are setting new standards in biologics

- Streamline Enzyme Discovery: Learn how to prioritize and engineer enzymes from early-stage proof of concept to accelerate your pipeline

- Fast-Track Decision Making: Master modern prediction methods and sophisticated high-throughput techniques to refine enzyme selection

- Optimize Small Molecule Biocatalysis: Gain insights from pharma-led projects focused on enhancing activity, yields and green chemistry

Join over 80 enzyme engineering, biocatalysis and process chemistry professionals from both industry and academia. Let's innovate and elevate drug development pipelines together through the power of green biocatalysis.

Date and Time: Tuesday, 10 December 2024 at 09:00 to Thursday, 12 December 2024 at 16:00